MYndspan is a brain analytics company empowering people with the most advanced tools to assess and monitor brain health using clinical-grade MEG (magnetoencephalography) scanning and validated metrics. They aim to extend the healthy lifespan of the mind by providing clear, objective insights into brain function to enable early action and tracking of changes over time.

Cognitive decline is not inevitable; MYndspan emphasizes that up to 45% of dementias are preventable with early intervention. Their technology makes advanced brain health assessments accessible beyond research labs, starting with a flagship scanning site in London.

The mission of MYndspan is to end preventable neurodegeneration through early detection, giving people the tools to understand and monitor their brain health with clinical precision.

They exist to close the gap caused by lack of awareness about brain function until symptoms arise. By bringing MEG technology directly to consumers, they aim to make brain health monitoring routine and accessible globally.

MYndspan is backed by science with functional brain metrics built on over 300 peer-reviewed MEG studies and is trusted by institutions such as Oxford and Cambridge. The company is led by a team of experts including co-founder and CEO Caitlin Baltzer and Chief Science Officer Dr. Benjamin Dunkley.